4-ethyl-1,3-dimethyl-1H-pyrazol-5-amine hydrate, 95.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(6-chloro-1H-indol-3-yl)propanoic acid, 97%, 25g

p-Quaterphenyl>98.0%(HPLC)1g

Bicyclo[1.1.1]pentane-1,3-diol, 98%, 250mg

4-(3-((4-Chloro-6-methoxyquinolin-7-yl)oxy)propyl)morpholine, 97%, 250mg

GC-Kapillarsäule ROTI®Cap-1701, L 60 m, Ø-Innen 0,25 mm, Filmd. 0,25 µm, 1 Stück

3-{[4-methyl-5-(3-pyridinyl)-4H-1,2,4-triazol-3-yl]thio}propanoic acid, 95.0%, 250mg

2-Chloro-4-fluoro-5-nitrophenol, 97.0%, 10g

5-HYDROXY-2,6-DIMETHYLPYRIDAZIN-3(2H)-ONE, 95.0%, 250mg

1-(2-CHLOROPHENYL)CYCLOBUTANE-1-CARBONITRILE, 95.0%, 250mg

tert-Butyl 3-(2-bromoacetyl)piperidine-1-carboxylate, 95.0%, 250mg

2-Chloro-3-nitroaniline, 95.0%, 100mg

tert-Butyldicyclohexylphosphoniumtetrafluoroborate, 98%, 25g